Press Releases KALA BIO, Inc.

Equities

KALA

US4831192020

Delayed Nasdaq Other stock markets 09:50:31 2024-05-13 EDT			5-day change	1st Jan Change
6.8 ^USD	-1.45%		-2.02%	-2.86%

04-02	HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating	MT
03-29	KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	04-01	AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	03-29	AQ
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	02-26	AQ
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	02-06	AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01-19	AQ
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	11-13	AQ
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	23-09-21	AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-09-20	AQ
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	23-09-05	AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-07	AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-04	AQ
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K	23-08-02	PU
KALA BIO to Participate in Upcoming Investor Conferences in August	23-08-02	AQ
Kala Pharmaceuticals Announces Name Change to KALA BIO	23-08-02	AQ
Kala Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	23-07-20	AQ
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-07-19	AQ
KALA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	23-06-23	AQ
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-06-23	AQ
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference	23-06-05	AQ
Kala Pharmaceuticals to Present at the Jefferies Healthcare Conference	23-06-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases KALA BIO, Inc.

Equities

KALA

US4831192020

Press Releases

Filters